These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
277 related items for PubMed ID: 27297911
1. von Willebrand factor and procoagulant imbalance predict outcome in patients with cirrhosis and thrombocytopenia. Kalambokis GN, Oikonomou A, Christou L, Kolaitis NI, Tsianos EV, Christodoulou D, Baltayiannis G. J Hepatol; 2016 Nov; 65(5):921-928. PubMed ID: 27297911 [Abstract] [Full Text] [Related]
2. von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis. Ferlitsch M, Reiberger T, Hoke M, Salzl P, Schwengerer B, Ulbrich G, Payer BA, Trauner M, Peck-Radosavljevic M, Ferlitsch A. Hepatology; 2012 Oct; 56(4):1439-47. PubMed ID: 22532296 [Abstract] [Full Text] [Related]
3. Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity. Mandorfer M, Schwabl P, Paternostro R, Pomej K, Bauer D, Thaler J, Ay C, Quehenberger P, Fritzer-Szekeres M, Peck-Radosavljevic M, Trauner M, Reiberger T, Ferlitsch A, Vienna Hepatic Hemodynamic Lab. Aliment Pharmacol Ther; 2018 Apr; 47(7):980-988. PubMed ID: 29377193 [Abstract] [Full Text] [Related]
4. Correlation between von Willebrand factor antigen, von Willebrand factor ristocetin cofactor activity and factor VIII activity in plasma. Lippi G, Franchini M, Salvagno GL, Montagnana M, Poli G, Guidi GC. J Thromb Thrombolysis; 2008 Oct; 26(2):150-3. PubMed ID: 17786534 [Abstract] [Full Text] [Related]
5. Factor VIII/protein C ratio independently predicts liver-related events but does not indicate a hypercoagulable state in ACLD. Scheiner B, Balcar L, Nussbaumer RJ, Weinzierl J, Paternostro R, Simbrunner B, Hartl L, Jachs M, Bauer D, Stättermayer AF, Semmler G, Pinter M, Ay C, Quehenberger P, Trauner M, Reiberger T, Lisman T, Mandorfer M. J Hepatol; 2022 May; 76(5):1090-1099. PubMed ID: 35066090 [Abstract] [Full Text] [Related]
6. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio. Gadisseur A, Berneman Z, Schroyens W, Michiels JJ. Acta Haematol; 2009 May; 121(2-3):128-38. PubMed ID: 19506359 [Abstract] [Full Text] [Related]
7. The Role of von Willebrand Factor Antigen in Predicting Survival of Patients with HBV-Related Cirrhosis. Pan Y, Guo R, Lv Y, Cui D, Xie J. Can J Gastroenterol Hepatol; 2022 May; 2022():9035971. PubMed ID: 35360443 [Abstract] [Full Text] [Related]
8. Von-Willebrand factor as a predictor of three-month mortality in patients with liver cirrhosis compared to MELD score. Curakova Ristovska E, Genadieva-Dimitrova M, Caloska-Ivanova V, Misevski J. Acta Gastroenterol Belg; 2019 May; 82(4):487-493. PubMed ID: 31950803 [Abstract] [Full Text] [Related]
13. Preservation of platelet function in patients with cirrhosis and thrombocytopenia undergoing esophageal variceal ligation. de Oliveira Souza E, D'Amico ÉA, Flores da Rocha TR, Marcondes Ferreira C, Medeiros Batista J, Carneiro D'Albuquerque LA, Carrilho FJ, Queiroz Farias A. Hepatobiliary Pancreat Dis Int; 2020 Dec; 19(6):555-560. PubMed ID: 31982344 [Abstract] [Full Text] [Related]
14. Von Willebrand factor antigen for detection of hepatopulmonary syndrome in patients with cirrhosis. Horvatits T, Drolz A, Roedl K, Herkner H, Ferlitsch A, Perkmann T, Müller C, Trauner M, Schenk P, Fuhrmann V. J Hepatol; 2014 Sep; 61(3):544-9. PubMed ID: 24798623 [Abstract] [Full Text] [Related]
15. DDAVP infusion in haemophilia A carriers: different behaviour of plasma factor VIII and von Willebrand factor. Casonato A, Dannhauser D, Pontara E, Bertomoro A, Orazi B, Santarossa L, Zerbinati P, Girolami A. Blood Coagul Fibrinolysis; 1996 Jul; 7(5):549-53. PubMed ID: 8874865 [Abstract] [Full Text] [Related]
16. A comparative multi-laboratory assessment of three factor VIII/von Willebrand factor concentrates. Favaloro EJ, Bukuya M, Martinelli T, Tzouroutis J, Duncan E, Welldon K, Collecutt M, Aumann H, Thom J, Gilmore G. Thromb Haemost; 2002 Mar; 87(3):466-76. PubMed ID: 11916080 [Abstract] [Full Text] [Related]
17. Similarity in joint and mucous bleeding syndromes in type 2N von Willebrand disease and severe hemophilia A coexisting with type 1 von Willebrand disease in two Chinese pedigrees. Qin HH, Xing ZF, Wang XF, Ding QL, Xi XD, Wang HL. Blood Cells Mol Dis; 2014 Apr; 52(4):181-5. PubMed ID: 24351655 [Abstract] [Full Text] [Related]
18. The von Willebrand Factor Facilitates Model for End-Stage Liver Disease-Independent Risk Stratification on the Waiting List for Liver Transplantation. Györi GP, Pereyra D, Rumpf B, Hackl H, Köditz C, Ortmayr G, Reiberger T, Trauner M, Berlakovich GA, Starlinger P. Hepatology; 2020 Aug; 72(2):584-594. PubMed ID: 31773739 [Abstract] [Full Text] [Related]
19. Rise of levels of von Willebrand factor and factor VIII with age: Role of genetic and acquired risk factors. Biguzzi E, Castelli F, Lijfering WM, Cannegieter SC, Eikenboom J, Rosendaal FR, van Hylckama Vlieg A. Thromb Res; 2021 Jan; 197():172-178. PubMed ID: 33221577 [Abstract] [Full Text] [Related]
20. Standardisation of factor VIII and von Willebrand factor in plasma: calibration of the 4th International Standard (97/586). Hubbard AR, Rigsby P, Barrowcliffe TW. Thromb Haemost; 2001 Apr; 85(4):634-8. PubMed ID: 11341497 [Abstract] [Full Text] [Related] Page: [Next] [New Search]